Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

Cholangiocarcinoma (CCA) is a heterogeneous disease arising from a complex interaction
between host‐specific genetic background and multiple risk factors. Globally, CCA …

Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms of the bile ducts and
represents the second most common hepatic cancer after hepatocellular carcinoma; it is sub …

Cholangiocarcinoma (CCA) encompasses a group of malignancies that can arise at any
point in the biliary tree. Although considered a rare cancer, the incidence of CCA is …

Antioxidant nanoparticles have recently gained tremendous attention for their enormous
potential in biomedicine. However, discrepant reports of either medical benefits or toxicity …

Peripheral blood of cancer patients “physiologically” presents cells and cellular components
deriving from primary or metastatic sites, including circulating tumor cells (CTCs), circulating …

Alterations in the human microbiota have been linked to carcinogenesis in several cancers.
To date, few studies have addressed the role of the microbiota in cholangiocarcinoma …

Cholangiocarcinoma (CCA) represents a heterogenous set of malignancies arising from the
biliary tract. Classification of CCA subdivides tumours into intrahepatic (iCCA) and …

Recent next-generation sequencing (NGS) studies on large cohorts of cholangiocarcinoma
(CCA) patients have clearly revealed the extreme intra-and inter-tumoral molecular …

Gallbladder cancer (GBC) is an aggressive neoplasm that in an early stage is generally
asymptomatic and, in most cases, is diagnosed in advanced stages with a very low life …